Literature DB >> 32794037

Lipid mass spectrometry imaging and proteomic analysis of severe aortic stenosis.

Jihyeon Lim1, Jennifer T Aguilan2,3, Rani S Sellers4, Fnu Nagajyothi5, Louis M Weiss2, Ruth Hogue Angeletti2,6,7, Anna E Bortnick8,9,10.   

Abstract

Severe aortic stenosis (AS) is prevalent in adults ≥ 65 years, a significant cause of morbidity and mortality, with no medical therapy. Lipid and proteomic alterations of human AS tissue were determined using mass spectrometry imaging (MSI) and liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) to understand histopathology, potential biomarkers of disease, and progression from non-calcified to calcified phenotype. A reproducible MSI method was developed using healthy murine aortic valves (n = 3) and subsequently applied to human AS (n = 2). Relative lipid levels were spatially mapped and associated with different microdomains. Proteomics for non-calcified and calcified microdomains were performed to ascertain differences in expression. Increased pro-osteogenic and inflammatory lysophosphatidylcholine (LPC) 16:0 and 18:0 were co-localized with calcified microdomains. Proteomics analysis identified differential patterns in calcified microdomains with high LPC and low cholesterol as compared to non-calcified microdomains with low LPC and high cholesterol. Calcified microdomains had higher levels of: apolipoproteins (Apo) B-100 (p < 0.001) and Apo A-IV (p < 0.001), complement C3 and C4-B (p < 0.001), C5 (p = 0.007), C8 beta chain (p = 0.013) and C9 (p = 0.010), antithrombotic proteins alpha-2-macroglobulin (p < 0.0001) and antithrombin III (p = 0.002), and higher anti-calcific fetuin-A (p = 0.02), while the osteoblast differentiating factor transgelin (p < 0.0001), extracellular matrix proteins versican, prolargin, and lumican ( p < 0.001) and regulator protein complement factor H (p < 0.001) were higher in non-calcified microdomains. A combined lipidomic and proteomic approach provided insight into factors potentially contributing to progression from non-calcified to calcific disease in severe AS. Additional studies of these candidates and protein networks could yield new targets for slowing progression of AS.

Entities:  

Keywords:  Calcific aortic valve stenosis; Cholesterol; Mass spectrometry imaging; Proteomics

Mesh:

Substances:

Year:  2020        PMID: 32794037      PMCID: PMC7672660          DOI: 10.1007/s10735-020-09905-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  54 in total

1.  Comparative lipidomics profiling of human atherosclerotic plaques.

Authors:  Christin Stegemann; Ignat Drozdov; Joseph Shalhoub; Julia Humphries; Christophe Ladroue; Athanasios Didangelos; Mark Baumert; Mark Allen; Alun H Davies; Claudia Monaco; Alberto Smith; Qingbo Xu; Manuel Mayr
Journal:  Circ Cardiovasc Genet       Date:  2011-04-21

Review 2.  Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues.

Authors:  Jan-Hung Chen; Craig A Simmons
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

3.  Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.

Authors:  Vincent M Brandenburg; Sebastian Reinartz; Nadine Kaesler; Thilo Krüger; Tim Dirrichs; Rafael Kramann; Frederique Peeters; Jürgen Floege; Andras Keszei; Nikolaus Marx; Leon J Schurgers; Ralf Koos
Journal:  Circulation       Date:  2017-05-23       Impact factor: 29.690

4.  Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

5.  Complement system is activated in stenotic aortic valves.

Authors:  Satu Helske; Riina Oksjoki; Ken A Lindstedt; Jyri Lommi; Heikki Turto; Kalervo Werkkala; Markku Kupari; Petri T Kovanen
Journal:  Atherosclerosis       Date:  2007-05-10       Impact factor: 5.162

6.  Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.

Authors:  Arun K Thukkani; Jane McHowat; Fong-Fu Hsu; Marie-Luise Brennan; Stanley L Hazen; David A Ford
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

7.  Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients.

Authors:  Ralf Koos; Vincent Brandenburg; Andreas Horst Mahnken; Georg Mühlenbruch; Sven Stanzel; Rolf W Günther; Jürgen Floege; Willy Jahnen-Dechent; Malte Kelm; Harald Peter Kühl
Journal:  Eur Heart J       Date:  2009-05-08       Impact factor: 29.983

8.  Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

Authors:  Rocco Romagnuolo; Santica M Marcovina; Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2014-01-29       Impact factor: 5.922

9.  In vivo isotopically labeled atherosclerotic aorta plaques in ApoE KO mice and molecular profiling by matrix-assisted laser desorption/ionization mass spectrometric imaging.

Authors:  Jose Castro-Perez; Nathan Hatcher; Nana Kofi Karikari; Sheng-Ping Wang; Vivienne Mendoza; Henry Shion; Alan Millar; John Shockcor; Mark Towers; David McLaren; Vinit Shah; Stephen Previs; Karen Akinsanya; Michele Cleary; Thomas P Roddy; Douglas G Johns
Journal:  Rapid Commun Mass Spectrom       Date:  2014-11-30       Impact factor: 2.419

Review 10.  Complement activation: an emerging player in the pathogenesis of cardiovascular disease.

Authors:  Angela M Carter
Journal:  Scientifica (Cairo)       Date:  2012-12-16
View more
  2 in total

1.  High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Anna E Bortnick; Petra Buzkova; James D Otvos; Majken K Jensen; Michael Y Tsai; Matthew J Budoff; Rachel H Mackey; Samar R El Khoudary; Elda Favari; Ryung S Kim; Carlos J Rodriguez; George Thanassoulis; Jorge R Kizer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-08-18       Impact factor: 10.514

2.  Measures of high-density lipoprotein function in men and women with severe aortic stenosis.

Authors:  Anouar Hafiane; Elda Favari; Anna E Bortnick
Journal:  Lipids Health Dis       Date:  2022-05-28       Impact factor: 4.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.